Reactive astrocytes, particularly the A1 phenotype, have emerged as critical contributors to neurodegenerative disease progression. Originally characterized by Liddelow et al. in 2017, A1 astrocytes are induced by microglial release of IL-1α, TNF, and C1q, and they acquire a neurotoxic phenotype that can harm neurons and oligodendrocytes. Understanding A1 astrocytes is essential for developing therapeutic strategies targeting neuroinflammation in Alzheimer's disease, Parkinson's disease, ALS, and other neurodegenerative conditions. [1]
Astrocytes are the most abundant glial cell type in the human brain, performing essential functions including: [2]
In disease states, astrocytes become "reactive" and undergo morphological and molecular changes. The A1 subtype represents a particularly harmful reactive state associated with neurodegeneration. [3]
A1 astrocytes upregulate a distinct set of genes: [4]
| Category | Examples | Function | [5]
|----------|----------|----------| [6]
| Complement proteins | C3, C4 | Synaptic pruning |
| Inflammatory mediators | IL-1β, TNF | Neuroinflammation |
| Cytokines | CCL2, CXCL10 | Immune recruitment |
| Stress proteins | GFAP, Vimentin | Reactive morphology |
A1 astrocytes are prominent in AD brain tissue:
A1 astrocytes contribute to dopaminergic neuron loss:
A1 astrocytes are highly relevant to ALS:
In contrast to A1, A2 astrocytes are considered protective:
The study of Reactive Astrocytes A1 Phenotype In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Liddelow et al. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017. ↩︎
Yun et al. (2018). A1 astrocytes in Parkinson's disease. Nature Neuroscience. 2018. ↩︎
Guttenplan et al. (2020). Toxicity of A1 astrocytes in ALS. Nature Neuroscience. 2020. ↩︎
Sofroniew (2020). Astrogliosis. Trends in Neurosciences. 2020. ↩︎
Clarke et al. (2018). A1 astrocytes in AD. Journal of Experimental Medicine. 2018. ↩︎
Escartin et al. (2021). Classification of reactive astrocytes. Nature Reviews Neuroscience. 2021. ↩︎